OXT-328

• CAT Number: I012313
• CAS Number: 1118973-90-2
• Molecular Formula: C28H34FO7PS
• Molecular Weight: 564.61
• Purity: ≥95%
• Synonyms: Phospho-sulindac; P-S; (1Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]-methylene]-1H-Indene-3-acetic acid 4-[(diethoxyphosphinyl)oxy]butyl ester
• IUPAC Name: 4-diethoxyphosphoryloxybutyl 2-[(3Z)-6-fluoro-2-methyl-3-[(4-methylsulfinylphenyl)methylidene]inden-1-yl]acetate
• InChI: InChI=1S/C28H34FO7PS/c1-5-34-37(31,35-6-2)36-16-8-7-15-33-28(30)19-26-20(3)25(24-14-11-22(29)18-27(24)26)17-21-9-12-23(13-10-21)38(4)32/h9-14,17-18H,5-8,15-16,19H2,1-4H3/b25-17-
• InChIKey: DTBSJPFGPBZPHE-UQQQWYQISA-N
• SMILES: CCOP(=O)(OCC)OCCCCOC(=O)CC1=C(C(=CC2=CC=C(C=C2)S(=O)C)C3=C1C=C(C=C3)F)C

OXT-328(CAT: I012313) is a novel sulindac derivative with dual anti-inflammatory and anti-cancer properties. By modulating key signaling pathways, it demonstrates efficacy in reducing inflammation and inhibiting tumor growth. This compound is particularly valuable in oncology and inflammation research, supporting studies on the chemopreventive and therapeutic potential of sulindac derivatives. OXT-328 provides a robust tool for investigating molecular mechanisms underlying inflammation and cancer progression, offering insights into the development of targeted therapies for inflammatory diseases and malignancies.